Implication of bevacizumab in fatal arterial thromboembolic incidents. [electronic resource]
Producer: 20090611Description: 115-7 p. digitalISSN:- 1107-0625
- Adenocarcinoma -- drug therapy
- Adult
- Angiogenesis Inhibitors -- adverse effects
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Anticoagulants -- therapeutic use
- Bevacizumab
- Fatal Outcome
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Maxillary Neoplasms -- drug therapy
- Middle Aged
- Sarcoma -- drug therapy
- Thromboembolism -- chemically induced
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.